Ignite Creation Date:
2024-05-06 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03343054
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2017-11-11
Brief Title:
A Phase 1 Study Of Talazoparib PARP Inhibitor In Japanese Patients With Advanced Solid Tumors
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-11
First Submit QC Date:
November 11 2017
Study First Post Date:
2017-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-03-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-26
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL